Supercharge Your Innovation With Domain-Expert AI Agents!

New Delhi metallo-beta-lactamase-1 inhibitors (NDM-1)

A technology of lactams and metals, which is applied in the field of medicine, can solve the problems of ineffective killing of "super bacteria", limited treatment options, and increased mortality of critically ill patients and infected people with low immunity.

Active Publication Date: 2020-10-23
MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Existing drugs cannot effectively kill the "super bacteria" containing NDM-1, which increases the fatality rate of critically ill patients and infected people with low immunity
Current treatment options for NDM-1-producing bacteria are very limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New Delhi metallo-beta-lactamase-1 inhibitors (NDM-1)
  • New Delhi metallo-beta-lactamase-1 inhibitors (NDM-1)
  • New Delhi metallo-beta-lactamase-1 inhibitors (NDM-1)

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0126] Experimental Example 1 NDM-1 Inhibitor Enzyme Activity Inhibition Experiment in Vitro

[0127] In this experiment, the NDM-1 inhibitors used were compound IMB-XH1, compound IMB-XH1Q and compounds IMB-XH1-1~IMB-XH1-110 in Table 1, and the NDM-1 inhibitors were first prepared with DMSO to a concentration The mother solution is 10mg / mL, and the mother solution is dissolved and diluted with DMSO as needed during the experiment. The substrate used in this experiment was meropenem (MEPM). MEPM was prepared into a mother solution with a concentration of 10mM with distilled water, and stored at -20°C. During the experiment, the mother solution was diluted with 10mM HEPES buffer as needed. The NDM-1 enzyme used in this experiment was first prepared with 10mM HEPES buffer solution to make a mother solution with a concentration of 2.8U (3.78nM). During the experiment, the mother solution was diluted with 10mM HEPES buffer solution as needed.

[0128] The inhibitory activity of ND...

experiment example 2

[0163] Experimental Example 2 Kinetic Study of NDM-1 Inhibitors on NDM-1

[0164]In this experiment, the NDM-1 inhibitors used were compound IMB-XH1 and compound IMB-XH1Q. First, the NDM-1 inhibitor was prepared with DMSO into a mother solution with a concentration of 10 mg / mL. During the experiment, it was dissolved and diluted with DMSO as needed. mother liquor. The substrate used in this experiment was meropenem (MEPM). MEPM was first prepared with water to make a mother solution with a concentration of 10 mM. During the experiment, the mother solution was diluted with 10 mM HEPES buffer as needed. The NDM-1 enzyme used in this experiment was first prepared with 10mM HEPES buffer solution to make a mother solution with a concentration of 2.8U (3.78nM). During the experiment, the mother solution was diluted with 10mM HEPES buffer solution as needed.

[0165] 2.1 Identification of reversible inhibition and irreversible inhibition

[0166] Experimental methods include:

[0...

experiment example 3

[0184] Experimental example 3 different NDM-1 inhibitors in vitro to the antibacterial activity evaluation of NDM-1 bacteria

[0185] In order to investigate whether different NDM-1 inhibitors have antibacterial effects on NDM-1-producing bacteria, drug sensitivity tests at the bacterial level were carried out using recombinant NDM-1-expressing engineering bacteria and other clinically isolated NDM-1-producing bacteria. The minimum inhibitory concentration (MIC) was determined by broth microdilution method.

[0186] In this experiment, the NDM-1 inhibitors used were compound IMB-XH1 and compound IMB-XH1Q. First, the NDM-1 inhibitor was prepared with DMSO into a mother solution with a concentration of 10 mg / mL. During the experiment, it was dissolved and diluted with DMSO as needed. mother liquor.

[0187] The substrates used in this experiment were β-lactam antibiotics (including ampicillin, ticarcillin, piperacillin, penicillin, cephalothin, cefoperazone, meropenem and aztre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of compounds as shown in a formula I which is described in the specification or stereoisomers or pharmaceutically acceptable salts thereof in preparation of drugsfor prevention and / or treatment of infections caused by bacteria, or in preparation of drugs used as NDM-1 inhibitors, or in preparation of antibacterial drugs. The invention further relates to application of combinations of the compounds as shown in the formula I or the stereoisomers or pharmaceutically acceptable salts thereof and beta-lactam antibiotics in preparation of drugs for preventing and / or treating infections caused by bacteria. The invention also relates to combined medicines which contain a preventive or therapeutic effective amount of at least one compound as shown in the formula I or the stereoisomer or pharmaceutically acceptable salt thereof and a preventive or therapeutic effective amount at least one beta-lactam antibiotic.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a New Delhi metallo-β-lactamase-1 inhibitor, which can be used to prevent and / or treat New Delhi metallo-β-lactamase-1 production - Lactamase-1 (NDM-1) bacterial infections. The present invention also relates to the use of the New Delhi metallo-β-lactamase-1 inhibitor in combination with β-lactam antibiotics for the preparation of medicaments for preventing and / or treating infections caused by bacteria. The present invention also relates to A combined drug comprising a prophylactically or therapeutically effective amount of at least one New Delhi metallo-β-lactamase-1 inhibitor and a prophylactically or therapeutically effective amount of at least one β-lactam antibiotic. Background technique [0002] Carrying New Delhi metallo-β-lactamase-1 (New Delhi metallo-β-lactamase-1, NDM-1) drug resistance gene (bla NDM ) bacteria is a new type of "super bacteria". Bacteria carrying...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D409/14C07D417/12C07D215/26C07D401/14C07D405/06C07D405/12C07D405/14C07D401/12A61K31/4709A61K31/47A61P31/04
CPCC07D409/14C07D417/12C07D215/26C07D401/14C07D405/06C07D405/12C07D405/14C07D401/12A61P31/04Y02A50/30
Inventor 刘忆霜肖春玲韩江雪甘茂罗关艳蒙建州王潇李兴华王颖郑佳音李东升刘琛楠
Owner MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More